Disease-Specific & Industry Reports

Decision Resources produces more than 150 reports each year.  They span a broad array of subjects, ranging from specific diseases or research pathways to analysis of key issues facing the biopharmaceutical industry today.

Our disease-specific reports are built from a network of more than 10,000 physicians, researcher, and formulary directors. Decision Resources integrates the input of these experts into an in-depth analysis of drivers that shape success or failure in drug development.  Each disease-specific report involves 8-10 staff who integrate epidemiology, clinical evaluations, and commercial dynamics into a comprehensive analysis and a 10-year forecast of the G7 markets.  The assumptions, sources of information, and methodologies are fully documented and transparent to facilitate greater usability and confidence in our analysis, models, and forecasts.

Our industry reports, published throughout the year, provide a constant window on the biopharmaceutical and healthcare markets. Through these concise business analyses, we provide alerts regarding key events, technologies, and issues that will impact these markets and deliver valuable data and analysis to guide industry knowledge and planning.

Access to Analysts
With the purchase of any Decision Resources report, you also get complete access to the analyst who authored the report. Clients can call analysts directly at anytime to discuss any aspect of the report’s content. Do you have a Decision Resources report you have questions on? Call Janet Sweeney, one of our customer service members, at +1-781-296-2549 to arrange to speak with an analyst.

For managed care reports, visit www.HealthLeaders-InterStudy.com.

For medical device and technology markets reports, visit www.MRG.net.